Cellectar Biosciences

CLRB

Börsenwert 12,1 Mio. $

#	Name	Position	Handelswert	Veränderung Aktien	Anteils- änderung
1	ACM 1 AIGH Capital Management Baltimore, Maryland	1,62 Mio. $	–	–	–
2	2 Vanguard Group Malvern, Pennsylvania	708.000 $	–	–	–
3	3 BlackRock New York	232.000 $	-65.844 $	-461	-19 %
4	4 Worth Venture Partners Fort Lee, New Jersey	225.000 $	–	–	–
5	5 Geode Capital Management Boston, Massachusetts	179.000 $	+1.143 $	+8	+0,5 %
6	6 Maven Securities St Helier, Jersey	162.000 $	–	–	–
7	7 ACT Capital Management Wayne, Pennsylvania	88.000 $	–	–	–
8	8 Renaissance Technologies New York	67.000 $	+18.853 $	+132	+31 %
9	9 State Street Boston, Massachusetts	63.000 $	+3.285 $	+23	+5 %
10	10 Bank of New York Mellon New York	49.000 $	-286 $	-2	-0,5 %
11	11 Franklin Resources San Mateo, California	42.000 $	-18.568 $	-130	-27 %
12	DCM 12 Difesa Capital Management New York	40.000 $	+42.848 $	+300	+909 %
13	13 Northern Trust Chicago, Illinois	39.000 $	–	–	–
14	14 Citadel Advisors Miami, Florida	28.000 $	+32.850 $	+230	Neu
15	15 Cozad Asset Management Champaign, Illinois	23.000 $	–	–	–
16	16 UBS Group Zurich, Switzerland	16.000 $	+10.998 $	+77	+140 %
17	17 Commonwealth Equity Services Waltham, Massachusetts	14.000 $	–	–	–
18	18 Modera Wealth Management Westwood, New Jersey	8.000 $	–	–	–
19	19 Tower Research Capital (TRC) New York	7.000 $	+3.856 $	+27	+96 %
20	20 Commerce Bank Kansas City, Missouri	6.000 $	–	–	–
21	21 Virtu Financial New York	6.000 $	+7.284 $	+51	Neu
22	22 Scotia Capital Toronto, Ontario, Canada	5.000 $	-143 $	-1	-3 %
23	23 Jane Street New York	5.000 $	+6.427 $	+45	Neu
24	24 Prospera Financial Services Dallas, Texas	2.000 $	-3.999 $	-28	-61 %
25	25 Osaic Holdings Scottsdale, Arizona	2.000 $	-143 $	-1	-6 %

Cellectar Biosciences CLRB Börsenwert 12,1 Mio. $

Cellectar Biosciences

CLRB

Börsenwert 12,1 Mio. $